---
title: "ZJJH released its performance for the first three quarters, with a net profit attributable to shareholders of RMB 3.248 billion, a year-on-year increase of 160.22%"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/262381715.md"
description: "According to the Zhitong Finance APP, ZJJH disclosed its third-quarter report for 2025. The company achieved revenue of 20.394 billion yuan in the first three quarters, a year-on-year increase of 13.89%; the net profit attributable to shareholders of the listed company was 3.248 billion yuan, a year-on-year increase of 160.22%; the net profit excluding non-recurring gains and losses was 3.199 billion yuan, a year-on-year increase of 170.13%; the basic earnings per share were 1.203 yuan"
datetime: "2025-10-23T08:48:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262381715.md)
  - [en](https://longbridge.com/en/news/262381715.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262381715.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/262381715.md) | [English](https://longbridge.com/en/news/262381715.md)


# ZJJH released its performance for the first three quarters, with a net profit attributable to shareholders of RMB 3.248 billion, a year-on-year increase of 160.22%

According to the Zhitong Finance APP, ZJJH (600160.SH) disclosed its third-quarter report for 2025. The company achieved a revenue of 20.394 billion yuan in the first three quarters, a year-on-year increase of 13.89%; the net profit attributable to shareholders of the listed company was 3.248 billion yuan, a year-on-year increase of 160.22%; the net profit excluding non-recurring gains and losses was 3.199 billion yuan, a year-on-year increase of 170.13%; the basic earnings per share were 1.203 yuan

### 相關股票

- [ZJJH (600160.CN)](https://longbridge.com/zh-HK/quote/600160.CN.md)

## 相關資訊與研究

- [Atalaya Mining CFO Increases Stake with Share Purchase](https://longbridge.com/zh-HK/news/281540905.md)
- [Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst⢠(bumetanide nasal spray)](https://longbridge.com/zh-HK/news/281570860.md)
- [Xinjiang Tianye Proposes Amendments to Articles to Reflect Evolving Business Scope](https://longbridge.com/zh-HK/news/281408816.md)
- [Strong Petrochemical Updates on Resumption Efforts and Ongoing Reporting Delays](https://longbridge.com/zh-HK/news/281220363.md)
- [PetroChina Renews Financial Deal With Related Company](https://longbridge.com/zh-HK/news/280998322.md)